Results 151 to 160 of about 89,490 (232)

Molecular Detection of Alpha- and Betacoronaviruses in Bats from Afar Region, Ethiopia. [PDF]

Vet Med Sci
Mengesha B, Romha G, Gebrezgabiher G.
europepmc   +1 more source

Modulation of Host Innate Immune Response by Highly Pathogenic Human Coronaviruses during Viral Infection. [PDF]

J Microbiol Biotechnol
Kim YJ, Lee SJ, Lee W, Kim SJ, Ahn DG.
europepmc   +1 more source

Seroprevalence of endemic and emergent coronaviruses among SARS-COV-2 patients and healthcare workers in Abidjan, Côte d'Ivoire. [PDF]

BMC Infect Dis
Menezes A, Koffi D, Rice BL, Metcalf CJE, Graham AL, Cauchemez S, Peeters M, Toure AO, Dosso M, Ayouba A, Roche B.   +10 more
europepmc   +1 more source

The DMV pore-forming TM2-Y region of SARS-CoV-2 nsp3 exhibits structural conservation beyond the coronavirus family. [PDF]

J Virol
Pozhidaeva A, Hoch JC, Pustovalova Y.
europepmc   +1 more source

Sequence Analysis of Feline Coronaviruses and the Circulating Virulent/Avirulent Theory

Emerging Infectious Diseases, 2011
Hui-Wen Chang, Herman F. Egberink, Peter J.M. Rottier   +2 more
doaj   +1 more source

Behind the membranous curtain-lipid dynamics and functions in coronaviral replication. [PDF]

J Virol
Salisch F, Müller-Ruttloff C.
europepmc   +1 more source

Identification and comparison of RNA structures in 5'- and 3'-terminal genomic regions across four coronavirus genera by SHAPE analysis. [PDF]

Virol J
Hsu HW, Hsu PC, Teng Y, Wang M, Hsieh FC, Yang CC, Wu HY.   +6 more
europepmc   +1 more source

Deciphering 6-mer Spectra Distribution Rules in Coronavirus Genomes: Application to Comparative Genomic Analysis. [PDF]

Int J Mol Sci
Yang Z, Li H, Li X, Liu G.
europepmc   +1 more source

Broad-spectrum CRISPR-Cas13d-mediated strategy for combating human coronaviruses. [PDF]

Mol Ther Nucleic Acids
Yu Z, Hussein M, Bao Y, Alcalá-Lalinde A, Kroon PZ, Thuillier E, Zhang Z, Enjuanes L, Zuñiga S, Berkhout B, Herrera-Carrillo E.   +10 more
europepmc   +1 more source

Inhibitory effects and structural analysis of drug candidate PF-07817883 against coronaviral main proteases (M^pro) and SARS-CoV-2 M^pro mutants. [PDF]

J Struct Biol X
Zhao Z, Zhou X, Jiang H, Wang W, Fan B, Li J.   +5 more
europepmc   +1 more source